BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11793970)

  • 21. [Modification at the 11 position of 18-methyl estradiol-3-methyl ether and the structure-antifertility relationship].
    Li ZS; Ling YZ; Ma CY
    Yao Xue Xue Bao; 1983 May; 18(5):339-44. PubMed ID: 6637485
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative effect of synthetic aminoestrogens with estradiol on platelet aggregation.
    De la Peña A; Baños G; Izaguirre R; Mandoki JJ; Fernández JM
    Steroids; 1993 Sep; 58(9):407-9. PubMed ID: 8236325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effect of prolame, a synthetic amino-estrogen, with estradiol and estrone on the contractility of the isolated rat myometrium.
    De la Peña A; López y López L; Ibañez R; Rubio-Póo C; Mandoki JJ; Perusquía M
    Proc West Pharmacol Soc; 1991; 34():85-7. PubMed ID: 1788348
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes on hemostatic parameters induced by 17beta-estradiol, ethinylestradiol, and the 17beta-aminoestrogen pentolame in the male Wistar rat.
    García-Manzano A; González-Llaven J; Jaimez R; Franco Y; Estela Avila M; Rubio-Póo C; Lemini C
    Steroids; 2002 Dec; 67(13-14):1129-35. PubMed ID: 12441199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anticoagulant effect of prolame, N-(3-hydroxy-1,3,5(10)estratrien-17 beta-yl)-3-hydroxypropylamine, a novel amino-estrogen.
    Rubio-Póo C; Mandoki JJ; Mendoza-Patiño N; Lemini C; de la Peña A; Cruz F; Zavala E; Silva G; Garcia-Mondragón J; Fernández JM
    Steroids; 1985 Feb; 45(2):159-70. PubMed ID: 3841425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dual effects of estrogens on blood clotting time.
    Mandoki JJ; Zavala E; Silva G; Mendoza-Patiño N; Rubio-Póo C; Medina-Martínez S; Domínguez-Escoto P
    Proc West Pharmacol Soc; 1983; 26():45-8. PubMed ID: 6310634
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of pyracantha fortuneana extract on blood coagulation].
    Mei X; Wan G; Zhou Z; Chang J; Wu H
    Zhong Yao Cai; 2001 Dec; 24(12):874-6. PubMed ID: 11917844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic aspects and actions unique to Estracyt.
    Sandberg AA
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):3-15. PubMed ID: 6364364
    [No Abstract]   [Full Text] [Related]  

  • 29. Pravastatin potentiates the anticoagulant effects of low molecular weight heparin.
    Zimmer JE; Spillert CR; Puppala S; Zamecki K; Bhatt BA; Arora RR
    Thromb Res; 2004; 113(6):407-10. PubMed ID: 15226096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and anticoagulation activity of sodium cellulose sulfate.
    Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
    Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dependence of the motor activity of female white rats on estrogen hormones].
    Polyshin VV; Mkhitarov VA
    Fiziol Zh SSSR Im I M Sechenova; 1984 Feb; 70(2):138-40. PubMed ID: 6714464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synthetic estrogen 4-estren-3 alpha,17 beta-diol (estren) induces estrogen-like neuroprotection.
    Cordey M; Gundimeda U; Gopalakrishna R; Pike CJ
    Neurobiol Dis; 2005; 19(1-2):331-9. PubMed ID: 15837589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological activity of novel factor Xa inhibitors: improving metabolic stability by S1 and S4 ligand modification.
    Komoriya S; Kobayashi S; Osanai K; Yoshino T; Nagata T; Haginoya N; Nakamoto Y; Mochizuki A; Nagahara T; Suzuki M; Shimada T; Watanabe K; Isobe Y; Furugoori T
    Bioorg Med Chem; 2006 Mar; 14(5):1309-30. PubMed ID: 16263291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
    Zhang C; Yu A; Yuan B; Dong C; Yu H; Wang L; Wu C
    Thromb Haemost; 2008 Feb; 99(2):324-30. PubMed ID: 18278181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prodiame: a new estrogen with sustained anticoagulant effect.
    Rubio-Póo C; Mandoki JJ; Jayme V; Mendoza-Patiño N; Alvarado C; Silva G; Zavala E; Fernández-González JM; Rubio-Arroyo M
    Proc West Pharmacol Soc; 1983; 26():111-3. PubMed ID: 6889323
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
    Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
    J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo.
    Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS
    Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and anticoagulant activities of substituted 2,4-diketochromans, biscoumarins, and chromanocoumarins.
    Manolov I; Maichle-Moessmer C; Nicolova I; Danchev N
    Arch Pharm (Weinheim); 2006 Jun; 339(6):319-26. PubMed ID: 16649158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats.
    Genazzani AR; Pluchino N; Begliuomini S; Pieri M; Centofanti M; Freschi L; Casarosa E; Luisi M
    Menopause; 2007; 14(1):63-73. PubMed ID: 17075429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plastic containers and the whole-blood clotting test: glass remains the best option.
    Stone R; Seymour J; Marshall O
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1168-72. PubMed ID: 16765393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.